-
1
-
-
80052444492
-
Vaccine stabilization: research, commercialization, and potential impact
-
21651941
-
Kristensen D, Chen D, Cummings R, (2011) Vaccine stabilization: research, commercialization, and potential impact. Vaccine29: 7122–7124. doi: 10.1016/j.vaccine.2011.05.070 21651941
-
(2011)
Vaccine
, vol.29
, pp. 7122-7124
-
-
Kristensen, D.1
Chen, D.2
Cummings, R.3
-
2
-
-
34247254237
-
Freezing temperatures in the vaccine cold chain: a systematic literature review
-
17382434
-
Matthias DM, Robertson J, Garrison MM, Newland S, Nelson C, (2007) Freezing temperatures in the vaccine cold chain: a systematic literature review. Vaccine25: 3980–3986. doi: 10.1016/j.vaccine.2007.02.052 17382434
-
(2007)
Vaccine
, vol.25
, pp. 3980-3986
-
-
Matthias, D.M.1
Robertson, J.2
Garrison, M.M.3
Newland, S.4
Nelson, C.5
-
3
-
-
33845206934
-
A vaccine cold chain freezing study in PNG highlights technology needs for hot climate countries
-
16968657
-
Wirkas T, Toikilik S, Miller N, Morgan C, Clements CJ, (2007) A vaccine cold chain freezing study in PNG highlights technology needs for hot climate countries. Vaccine25: 691–697. doi: 10.1016/j.vaccine.2006.08.028 16968657
-
(2007)
Vaccine
, vol.25
, pp. 691-697
-
-
Wirkas, T.1
Toikilik, S.2
Miller, N.3
Morgan, C.4
Clements, C.J.5
-
4
-
-
56949089493
-
Characterization of the freeze sensitivity of a hepatitis B vaccine
-
18971625
-
Chen D, Tyagi A, Carpenter J, Perkins S, Sylvester D, et al. (2009) Characterization of the freeze sensitivity of a hepatitis B vaccine. Hum Vaccin5: 26–32. 18971625
-
(2009)
Hum Vaccin
, vol.5
, pp. 26-32
-
-
Chen, D.1
Tyagi, A.2
Carpenter, J.3
Perkins, S.4
Sylvester, D.5
-
5
-
-
65649124108
-
Opportunities and challenges of developing thermostable vaccines
-
19397412
-
Chen D, Kristensen D, (2009) Opportunities and challenges of developing thermostable vaccines. Expert Rev Vaccines8: 547–557. doi: 10.1586/erv.09.20 19397412
-
(2009)
Expert Rev Vaccines
, vol.8
, pp. 547-557
-
-
Chen, D.1
Kristensen, D.2
-
6
-
-
84901249588
-
Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines
-
24665982
-
Deering RP, Kommareddy S, Ulmer JB, Brito LA, Geall AJ, (2014) Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines. Expert Opin Drug Deliv11: 885–899. doi: 10.1517/17425247.2014.901308 24665982
-
(2014)
Expert Opin Drug Deliv
, vol.11
, pp. 885-899
-
-
Deering, R.P.1
Kommareddy, S.2
Ulmer, J.B.3
Brito, L.A.4
Geall, A.J.5
-
7
-
-
84978063234
-
An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs
-
27336830
-
Schnee M, Vogel AB, Voss D, Petsch B, Baumhof P, et al. (2016) An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs. PLoS Negl Trop Dis10: e0004746. doi: 10.1371/journal.pntd.0004746 27336830
-
(2016)
PLoS Negl Trop Dis
, vol.10
, pp. e0004746
-
-
Schnee, M.1
Vogel, A.B.2
Voss, D.3
Petsch, B.4
Baumhof, P.5
-
8
-
-
84870869040
-
Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
-
23159882
-
Petsch B, Schnee M, Vogel AB, Lange E, Hoffmann B, et al. (2012) Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection. Nat Biotechnol30: 1210–1216. doi: 10.1038/nbt.2436 23159882
-
(2012)
Nat Biotechnol
, vol.30
, pp. 1210-1216
-
-
Petsch, B.1
Schnee, M.2
Vogel, A.B.3
Lange, E.4
Hoffmann, B.5
-
9
-
-
36448956746
-
Long-term storage of DNA-free RNA for use in vaccine studies
-
18072597
-
Jones KL, Drane D, Gowans EJ, (2007) Long-term storage of DNA-free RNA for use in vaccine studies. Biotechniques43: 675–681. 18072597
-
(2007)
Biotechniques
, vol.43
, pp. 675-681
-
-
Jones, K.L.1
Drane, D.2
Gowans, E.J.3
-
10
-
-
78650640612
-
Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity
-
21150709
-
Fotin-Mleczek M, Duchardt KM, Lorenz C, Pfeiffer R, Ojkic-Zrna S, et al. (2011) Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity. J Immunother34: 1–15. doi: 10.1097/CJI.0b013e3181f7dbe8 21150709
-
(2011)
J Immunother
, vol.34
, pp. 1-15
-
-
Fotin-Mleczek, M.1
Duchardt, K.M.2
Lorenz, C.3
Pfeiffer, R.4
Ojkic-Zrna, S.5
-
11
-
-
0033989908
-
In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies
-
10602021
-
Hoerr I, Obst R, Rammensee HG, Jung G, (2000) In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies. Eur J Immunol30: 1–7. doi: 10.1002/1521-4141(200001)30:1<1::AID-IMMU1>3.0.CO;2-# 10602021
-
(2000)
Eur J Immunol
, vol.30
, pp. 1-7
-
-
Hoerr, I.1
Obst, R.2
Rammensee, H.G.3
Jung, G.4
-
12
-
-
85025815073
-
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
-
Alberer M, Gnad-Vogt U, Hong HS, Mehr KT, Backert L, et al. (2017) Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial. Lancet.
-
(2017)
Lancet
-
-
Alberer, M.1
Gnad-Vogt, U.2
Hong, H.S.3
Mehr, K.T.4
Backert, L.5
-
13
-
-
39349103969
-
Vaccination with messenger RNA (mRNA)
-
Pascolo S, (2008) Vaccination with messenger RNA (mRNA). Handb Exp Pharmacol: 221–235.
-
(2008)
Handb Exp Pharmacol
, pp. 221-235
-
-
Pascolo, S.1
-
14
-
-
0032029478
-
Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody
-
9671155
-
Cliquet F, Aubert M, Sagné L, (1998) Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody. Journal of Immunological Methods212: 79–87. 9671155
-
(1998)
Journal of Immunological Methods
, vol.212
, pp. 79-87
-
-
Cliquet, F.1
Aubert, M.2
Sagné, L.3
-
15
-
-
62749127010
-
Induction of immune responses and protection in mice against rabies using a self-replicating RNA vaccine encoding rabies virus glycoprotein
-
19081687
-
Saxena S, Sonwane AA, Dahiya SS, Patel CL, Saini M, et al. (2009) Induction of immune responses and protection in mice against rabies using a self-replicating RNA vaccine encoding rabies virus glycoprotein. Vet Microbiol136: 36–44. doi: 10.1016/j.vetmic.2008.10.030 19081687
-
(2009)
Vet Microbiol
, vol.136
, pp. 36-44
-
-
Saxena, S.1
Sonwane, A.A.2
Dahiya, S.S.3
Patel, C.L.4
Saini, M.5
-
16
-
-
36349015882
-
Assessing the relationship between antigenicity and immunogenicity of human rabies vaccines. Results of a meta-analysis
-
17033270
-
Sudarshan MK, Mahendra BJ, Madhusudana SN, Narayana DH, Sanjay TV, et al. (2005) Assessing the relationship between antigenicity and immunogenicity of human rabies vaccines. Results of a meta-analysis. Hum Vaccin1: 187–190. 17033270
-
(2005)
Hum Vaccin
, vol.1
, pp. 187-190
-
-
Sudarshan, M.K.1
Mahendra, B.J.2
Madhusudana, S.N.3
Narayana, D.H.4
Sanjay, T.V.5
-
17
-
-
84992212831
-
Thermotolerance of an inactivated rabies vaccine for dogs
-
27729174
-
Lankester FJ, Wouters PA, Czupryna A, Palmer GH, Mzimbiri I, et al. (2016) Thermotolerance of an inactivated rabies vaccine for dogs. Vaccine34: 5504–5511. doi: 10.1016/j.vaccine.2016.10.015 27729174
-
(2016)
Vaccine
, vol.34
, pp. 5504-5511
-
-
Lankester, F.J.1
Wouters, P.A.2
Czupryna, A.3
Palmer, G.H.4
Mzimbiri, I.5
-
18
-
-
84933280519
-
Rabies vaccine preserved by vaporization is thermostable and immunogenic
-
25812841
-
Smith TG, Siirin M, Wu X, Hanlon CA, Bronshtein V, (2015) Rabies vaccine preserved by vaporization is thermostable and immunogenic. Vaccine33: 2203–2206. doi: 10.1016/j.vaccine.2015.03.025 25812841
-
(2015)
Vaccine
, vol.33
, pp. 2203-2206
-
-
Smith, T.G.1
Siirin, M.2
Wu, X.3
Hanlon, C.A.4
Bronshtein, V.5
|